Official product information
How Sciatica Pro Works: The Claim, and the Federal Record Beside It
What the two claims on the front actually say, what the federal record publishes about the ten printed ingredients, and why the gap between diabetic neuropathy and sciatica is left standing on this page rather than bridged.
Quick answer
The front of the bottle carries two structure/function claims, Clinically Studied Ingredients and Supports Nerve Health, each with a dagger resolving to the FDA disclaimer. Neither names a condition. Three of the ten ingredients carry named clinical trials, and all three of those trials were run in diabetic neuropathy, which is nerve damage from high blood sugar. MedlinePlus says sciatica occurs when there is pressure on or damage to the sciatic nerve. No trial cited on this site was carried out in sciatica, and this page claims no mechanism for it.
01 The condition, from the federal pages
What sciatica is, in MedlinePlus’s own words
A symptom of a problem with the largest nerve in the body, and three named causes, all of them mechanical.
Any honest answer to how does it work has to start with the condition rather than with the capsule, so this page starts with MedlinePlus, quoted rather than summarised.
MedlinePlus: “Sciatica is a symptom of a problem with the sciatic nerve, the largest nerve in the body.” Note the word symptom. “When you have sciatica, you have pain, weakness, numbness, or tingling.” “It can start in the lower back and extend down your leg to your calf, foot, or even your toes.” “It’s usually on only one side of your body.” The Medical Encyclopedia adds that the pain “Sciatica pain can vary widely. It may feel like a mild tingling, dull ache, or burning sensation.” and “The pain most often occurs on one side of the body.”
MedlinePlus names three causes: “A ruptured intervertebral disk”, “Narrowing of the spinal canal that puts pressure on the nerve, called spinal stenosis”, and “An injury such as a pelvic fracture.” And then the sentence that should govern every expectation anybody brings to a product in this category: “In many cases no cause can be found.” All three named causes are mechanical — something pressing on a nerve.
Some back and leg pain is not a shopping question. MedlinePlus Medical Encyclopedia, on sciatica, under When to Contact a Medical Professional, prints the instruction as “Contact your provider right away if you have:” and then lists nine symptoms. All nine are below, in MedlinePlus’s own words and in the order it prints them. If any of them describes you, stop reading this site and make the call. Nothing on this page is more important than that, and no supplement is.
- Unexplained fever with back pain
- Back pain after a severe blow or fall
- Redness or swelling on the back or spine
- Pain traveling down your legs below the knee
- Weakness or numbness in your buttocks, thigh, leg, or pelvis
- Burning with urination or blood in your urine
- Pain that is worse when you lie down, or awakens you at night
- Severe pain and you cannot get comfortable
- Loss of control of urine or stool (incontinence)
Those nine are the ones MedlinePlus puts under “Contact your provider right away if you have:” — they are printed here complete and unedited, because a shortened safety list is a worse thing than no safety list. The same page prints a second and slower list under “Also contact your provider if:”: you have been losing weight unintentionally; you use steroids or inject illicit drugs; you have had back pain before, but this episode is different and feels worse; and this episode of back pain has lasted longer than 4 weeks. Those four are reasons to be seen rather than reasons to go now, and the distinction between the two lists is MedlinePlus’s own rather than this desk’s.
This matters more on a site about this product than it would on almost any other. A capsule bought online is a thing you can start taking tonight without telling anybody, and the one cost of that is the weeks it can absorb while a symptom that needed a clinician goes unreported. If you have any of the symptoms above, the correct next step is a provider, today, not a purchase.
2 claims on the front of the bottle
The two claims on the front, and the narrow question they leave
Clinically studied ingredients, and supports nerve health. Neither names a condition.
Now the bottle. The front carries exactly two claims and no more: “Clinically Studied Ingredients†” and “Supports Nerve Health†”. Both are structure/function claims, both carry a dagger, and the dagger resolves on the back to the full FDA disclaimer. Neither of them is a claim about sciatica. The front does not say the product treats, relieves, eases or cures anything, and neither does this site.
So the question this page can actually answer is narrow, and it is worth stating exactly. What does the federal record publish about the ten ingredients printed on this panel, and what condition was each of those publications about? Everything below is an answer to that question and to nothing wider. No trial of this finished formula was supplied to this desk, and an ingredient result does not transfer to a finished product at a different amount in a different dose form — which is why the fractions from the ten amounts page are carried into every section here.
02 Two conditions, one sentence
Diabetic neuropathy and sciatica sit in one federal sentence, and are not one condition
NINDS names both as causes of neuropathic pain. One is metabolic damage; the other is pressure on a nerve.
Here is the sentence that decides how to read the three trials on this panel, and it comes from NINDS: “Examples of conditions that cause neuropathic pain are diabetic neuropathy, shingles, and sciatica.” Diabetic neuropathy and sciatica sit in the same federal sentence, which is exactly why the comparison has to be made carefully rather than waved away. They are both neuropathic pain and they are not the same condition. MedlinePlus on the one this product is named after: “Sciatica occurs when there is pressure on or damage to the sciatic nerve.” Pressure on a nerve is mechanical. Diabetic polyneuropathy is metabolic nerve damage. No trial named anywhere on this site studied sciatica. That is not a claim that the ingredients are useless here: an ingredient studied in one nerve condition is not thereby useless in another. It is simply untested there, and untested is the accurate word.
Of the ten ingredients on this panel, four have a NIH Office of Dietary Supplements consumer fact sheet — vitamin D3, vitamin B6, folate and vitamin B12 — and those four are the rows where a printed amount can be set against a recommended amount and an upper limit. Three carry a named clinical trial: alpha lipoic acid, benfotiamine and acetyl L-carnitine, all three in diabetic neuropathy. Three have no federal consumer amount for nerve pain at all: ashwagandha, broccoli and turmeric, each printed at 25 mg. For those three the honest report is that they are present, that the amount is small, and that nothing federal gives a figure to compare it with.
0 of those trials were carried out in sciatica
The three trials, and the condition each one was run in
Named, published, and every one of them in diabetic neuropathy.
Three of the ten rows carry a named clinical trial. Here are all three, with the population, the doses, the fraction this label prints and the authors’ own conclusion, so that nothing has to be taken on trust.
| Row | The trial | Condition studied | Printed, against studied | The conclusion, verbatim |
|---|---|---|---|---|
| Alpha Lipoic Acid | SYDNEY 2: oral doses of 600 mg, 1,200 mg and 1,800 mg once daily, five weeks, 181 patients in Russia and Israel | diabetic distal symmetric polyneuropathy | 400 mg of 600 mg once daily — two thirds | “An oral dose of 600 mg once daily appears to provide the optimum risk-to-benefit ratio.” |
| Benfotiamine | a placebo-controlled trial at 300 mg a day and 600 mg a day, six weeks, 165 randomised | symmetrical distal diabetic polyneuropathy | 150 mg of 300 mg a day — one half | “Benfotiamine may extend the treatment option for patients with diabetic polyneuropathy.” |
| Acetyl L-Carnitine | a Cochrane review of four trials and about 906 participants, at 1,500 mg, 2,000 mg and 3,000 mg a day | diabetic peripheral neuropathy | 50 mg of 1,500 mg a day — one thirtieth | “We are uncertain whether ALC reduces pain in DPN, as the evidence is sparse and of very low certainty.” |
Three trials, three conditions, and all three of those conditions are forms of diabetic neuropathy. None of these trials was carried out in sciatica.
That table is the whole evidence base for the front-of-bottle phrase, and it is worth being precise about what it does and does not establish. It establishes that the phrase “Clinically Studied Ingredients†” is literally true of three rows out of ten. It does not establish anything about sciatica, because no trial in it was run in sciatica, and it does not establish anything about these amounts, because every trial in it used more.
1 deliberate absence: no mechanism is claimed
The gap between the two conditions is not bridged on this page
Compression is not metabolic damage, and no published work joins the two for these ingredients.
This is the section where a page like this one usually bridges the gap with a sentence about nerves in general. This page does not, and the reason is worth setting out rather than asserting.
MedlinePlus on the condition on the front of the bottle: “Sciatica occurs when there is pressure on or damage to the sciatic nerve.” The three causes it names are “A ruptured intervertebral disk”, “Narrowing of the spinal canal that puts pressure on the nerve, called spinal stenosis” and “An injury such as a pelvic fracture.” — a disc, a narrowed canal, an injury. All three are mechanical: something is pressing on a nerve. The trials in the table above were run in diabetic polyneuropathy, which is nerve damage from high blood sugar. A dose that was measured against metabolic nerve damage has not been measured against a compressed nerve, and nothing in the supplied material measures it there.
So this page states no mechanism for sciatica, and that is a deliberate absence rather than an oversight. There is no published mechanism to state for these ingredients in this condition, and inventing a plausible-sounding one would be the single most dishonest thing this site could do. What can be said is the shape of the gap: three ingredients with real trials, in the wrong condition, at smaller amounts than those trials used, in a capsule named after a condition none of them was tested in.
The opposite overstatement is also refused here. Untested is not the same as disproved. No trial supplied to this desk shows that these ingredients do nothing in sciatica, because no trial supplied to this desk studied them in sciatica. The honest word is the narrow one, and the narrow one is untested.
03 The rest of the federal frame
What NINDS and MedlinePlus put in the frame instead
Five named approaches, a condition that sometimes resolves on its own, and treatment that depends on the cause.
NINDS, on approaches outside medicine and surgery: “Research has shown that some complementary health approaches can improve pain in some people. These include acupuncture, chiropractic care, massage therapy, tai chi, and others.” Dietary supplements are not in that list. That is not a finding against them; it is a federal sentence that names five things and does not name a sixth, and it is quoted here because a reader weighing a purchase deserves to see what else the federal record puts in the frame.
Two more sentences from MedlinePlus, and they are the two people search for most. “Sometimes sciatica goes away on its own.” And: “Treatment, if needed, depends on the cause of the problem. It may include exercises, medicines, and surgery.” Read those together and the shape of the thing is clear: the course varies, improvement without treatment happens, and what is done about it depends on what is causing it. Nothing in that sentence is a capsule, and nothing on this site says otherwise.
Those two passages together are the most useful thing on this page for somebody deciding what to do next, and they are both federal. One names five approaches that research has shown can improve pain in some people. The other says the course varies, that improvement without treatment happens, and that what is done about it depends on what is causing it. A capsule appears in neither sentence.
0 published trials of this formula
Three statements, and no fourth
What can be said, what cannot, and what would change it.
So where does that leave somebody who came here for an answer? With three statements that can be made and no fourth.
One. Nobody can tell you whether this product works in sciatica. No trial of the formula exists in the supplied material, and no trial of any of its ingredients in the supplied material was run in sciatica.
Two. The ingredient evidence that does exist is real, named and published — and it is attached to a different condition and to larger amounts: two thirds, one half and one thirtieth of the studied doses, all three measured in diabetic neuropathy.
Three. The label itself is careful. It prints an amount for every one of the ten rows, gets all four of its percentages right, keeps vitamin B6 at 1.7 mg, claims nothing about a disease on the front, and marks both of its structure/function claims with a dagger that resolves to the disclaimer.
What would change this page
A randomised, placebo-controlled trial of this formula, at these amounts, in this dose form, in people with sciatica, published where a reader can check it. Until something like that exists, the useful question is not whether the capsule works but whether anything on the label is a reason for you in particular not to take it — and that question is answered on the side effects page and with your own clinician. If what prompted the search was a symptom that is new, severe or getting worse, the red flags at the top of this page are the part of it that matters.
Questions
Sciatica Pro FAQ: how it works questions
Does Sciatica Pro work?
No trial of this formula has been published, so nobody can answer that from evidence — not this desk and not the seller. What exists is three ingredients with named trials, all of them in diabetic neuropathy, all of them at larger amounts than this label prints. No trial cited anywhere on this site studied sciatica.
Are diabetic neuropathy and sciatica the same thing?
No, although they sit in the same federal sentence. NINDS: “Examples of conditions that cause neuropathic pain are diabetic neuropathy, shingles, and sciatica.” Both are neuropathic pain. One is metabolic nerve damage and the other is pressure on a nerve, and a trial in one is not a trial in the other.
Why do the trials not count for sciatica?
Because they were in a different condition and this site says so plainly rather than softening it. All three were in diabetic neuropathy, which is metabolic nerve damage. MedlinePlus: “Sciatica occurs when there is pressure on or damage to the sciatic nerve.” Compression is a different mechanism. That does not make the ingredients useless here — it makes them untested here.
Does Sciatica Pro help nerve pain?
This site does not say that it does, because nothing published supports it. What the bottle says is “Supports Nerve Health†”, a structure/function claim carrying the FDA disclaimer. FDA does not review such a claim before it is used.
Is sciatica nerve pain?
NINDS lists it as such: “Examples of conditions that cause neuropathic pain are diabetic neuropathy, shingles, and sciatica.” All three are neuropathic pain, and all three are different conditions — which is exactly why a trial in one of them is not a trial in another.
What would prove Sciatica Pro works?
A randomised placebo-controlled trial of this formula, at these amounts, in people with sciatica, published somewhere a reader can check. Not an ingredient trial at a larger dose in a different condition, and not a review wall.
References
Sources for this page
- MedlinePlus, U.S. National Library of Medicine. Sciatica. medlineplus.gov. Accessed October 11, 2026.
- MedlinePlus Medical Encyclopedia, U.S. National Library of Medicine. Sciatica (Medical Encyclopedia). medlineplus.gov. Accessed October 11, 2026.
- National Institute of Neurological Disorders and Stroke. Back Pain. www.ninds.nih.gov. Accessed October 11, 2026.
- Ziegler D and others, Diabetes Care. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. pubmed.ncbi.nlm.nih.gov. Accessed October 11, 2026.
- Stracke H and others, Experimental and Clinical Endocrinology & Diabetes. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double-blind, placebo-controlled clinical study. pubmed.ncbi.nlm.nih.gov. Accessed October 11, 2026.
- Cochrane Database of Systematic Reviews. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. www.cochrane.org. Accessed October 11, 2026.
Next
Keep reading
The ten amounts, against what was studied
Two thirds, one half and one thirtieth, with the shortfall drawn.
Read itClaimed against evidenced
What each ingredient is for on its own federal fact sheet.
Read itThe cautions that are published
Vitamin B6, folate and B12, and the three rows with no fact sheet.
Read itOrder Sciatica Pro from the official page
60 capsules a bottle, two a day, thirty days a bottle. Ten ingredients, ten printed amounts, no proprietary blend, and about 677 mg of declared actives a serving. Price and guarantee are read from the live checkout. Order support +1 (302) 200-3480.
Price and guarantee are read on the checkout page — screenshot it with the date before you pay · ships from inside the US · order support +1 (302) 200-3480